[1] Fan E, Cheek F, Chlan L, et al. An official American thoracic society clinical practice guideline: the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med, 2014; 190, 1437−46. doi:  10.1164/rccm.201411-2011ST
[2] Chen J, Huang M. Intensive care unit-acquired weakness: recent insights. J Intensive Med, 2024; 4, 73−80. doi:  10.1016/j.jointm.2023.07.002
[3] Gu B, Zhou Y, Shi R, et al. Use of muscular ultrasound to detect intensive care unit-acquired weakness: a systematic review and meta-analysis. Shock, 2025; 63, 19−29. doi:  10.1097/SHK.0000000000002484
[4] Boelens YFN, Melchers M, van Zanten ARH. Poor physical recovery after critical illness: incidence, features, risk factors, pathophysiology, and evidence-based therapies. Curr Opin Crit Care, 2022; 28, 409−16. doi:  10.1097/mcc.0000000000000955
[5] Meyer-Frießem CH, Malewicz NM, Rath S, et al. Incidence, time course and influence on quality of life of intensive care unit-acquired weakness symptoms in long-term intensive care survivors. J Intensive Care Med, 2021; 36, 1313−22. doi:  10.1177/0885066620949178
[6] Bellaver P, Schaeffer AF, Leitao CB, et al. Association between neuromuscular blocking agents and the development of intensive care unit-acquired weakness (ICU-AW): a systematic review with meta-analysis and trial sequential analysis. Anaesth Crit Care Pain Med, 2023; 42, 101202. doi:  10.1016/j.accpm.2023.101202
[7] Peñuelas O, Keough E, López-Rodríguez L, et al. Ventilator-induced diaphragm dysfunction: translational mechanisms lead to therapeutical alternatives in the critically ill. Intensive Care Med Exp, 2019; 7, 48. doi:  10.1186/s40635-019-0259-9
[8] Schefold JC, Bierbrauer J, Weber-Carstens S. Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle, 2010; 1, 147−57. doi:  10.1007/s13539-010-0010-6
[9] Mankowski RT, Laitano O, Darden D, et al. Sepsis-induced myopathy and gut microbiome dysbiosis: mechanistic links and therapeutic targets. Shock, 2022; 57, 15−23. doi:  10.1097/SHK.0000000000001843
[10] Pierre A, Favory R, Brassart B, et al. Sepsis induces long-term muscle and mitochondrial dysfunction due to autophagy disruption amenable by urolithin A. J Cachexia Sarcopenia Muscle, 2025; 16, e70041. doi:  10.1002/jcsm.70041
[11] Zhou Y, Sun YJ, Pan YF, et al. Risk prediction models for intensive care unit-acquired weakness in critically ill patients: a systematic review. Aust Crit Care, 2025; 38, 101066. doi:  10.1016/j.aucc.2024.05.003
[12] Guo Y, Shan WP, Xiang J. Predictive modeling of ICU-AW inflammatory factors based on machine learning. BMC Neurol, 2024; 24, 483. doi:  10.1186/s12883-024-03981-w
[13] Zhang YM, Wang Y, Yang JR, et al. Development and validation of machine learning-based risk prediction models for ICU-acquired weakness: a prospective cohort study. Eur J Med Res, 2025; 30, 666. doi:  10.1186/s40001-025-02930-8
[14] Mușat F, Păduraru DN, Bolocan A, et al. Machine learning models in sepsis outcome prediction for ICU patients: integrating routine laboratory tests-a systematic review. Biomedicines, 2024; 12, 2892. doi:  10.3390/biomedicines12122892
[15] Yang J, Yan CH, Chen SL, et al. The possible mechanisms of ferroptosis in sepsis-associated acquired weakness. Front Physiol, 2024; 15, 1380992. doi:  10.3389/fphys.2024.1380992
[16] Ojima M, Shimizu K, Motooka D, et al. Gut dysbiosis associated with antibiotics and disease severity and its relation to mortality in critically Ill patients. Dig Dis Sci, 2022; 67, 2420−32. doi:  10.1007/s10620-021-07000-7
[17] Tran A, Walsh CJ, Batt J, et al. A machine learning-based clinical tool for diagnosing myopathy using multi-cohort microarray expression profiles. J Transl Med, 2020; 18, 454. doi:  10.1186/s12967-020-02630-3
[18] Bian L, Wang FB, Yang Y, et al. Monotropein alleviates sepsis-induced spleen injury by inhibiting the NF-κB/NLRP3 axis and activating the Nrf2 pathway. Biomed Environ Sci, 2025; 38, 270−6.
[19] Fuentes-Aspe R, Gutierrez-Arias R, González-Seguel F, et al. Which factors are associated with acquired weakness in the ICU? An overview of systematic reviews and meta-analyses. J Intensive Care, 2024; 12, 33. doi:  10.1186/s40560-024-00744-0
[20] Ding M, Yang CF, Qin YL, et al. Risk factors and 6-month outcomes of paediatric intensive care unit-acquired weakness. Aust Crit Care, 2025; 38, 101294. doi:  10.1016/j.aucc.2025.101294
[21] Yang Z, Wang XH, Wang FY, et al. A systematic review and meta-analysis of risk factors for intensive care unit acquired weakness. Medicine (Baltimore), 2022; 101, e31405. doi:  10.1097/MD.0000000000031405
[22] Liu YY, Li LF. Ventilator-induced diaphragm dysfunction in critical illness. Exp Biol Med (Maywood), 2018; 243, 1329−37.